Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
{{output}}
In parallel with the obesity epidemic, nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver disease worldwide. Disequilibrium of lipid metabolism and the subsequent metabolic-stress-induced inflammation are believed to be centr... ...